您当前的位置:
首页 >
文章列表页 >
Expert Consensus on Clinical Application of Yifei Zhike Capsules
更新时间:2025-05-07
    • Expert Consensus on Clinical Application of Yifei Zhike Capsules

    • According to the latest report, Hongyun Pharmaceutical (Guizhou) Co., Ltd.'s exclusive Miao medicine Yifei Zhike Capsule has been developed by 30 experts using evidence-based medicine methods to establish a consensus, which clarifies its syndrome characteristics, disease staging, dosage, course of treatment, and combination therapy in the treatment of acute/chronic bronchitis and pulmonary tuberculosis, providing scientific basis for rational clinical application.
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 11, Pages: 218-224(2025)
    • DOI:10.13422/j.cnki.syfjx.20251391    

      CLC: R242;R256.1;R56
    • Received:08 February 2025

      Accepted:17 March 2025

      Published Online:14 April 2025

      Published:05 June 2025

    移动端阅览

  • CUI Xin,ZHANG Hongchun,GUO Weiwei,et al.Expert Consensus on Clinical Application of Yifei Zhike Capsules[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(11):218-224. DOI: 10.13422/j.cnki.syfjx.20251391.

  •  
  •  

0

Views

374

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Compilation Instructions for Expert Consensus on Clinical Application of Yifei Zhike Capsules
Compilation Instructions for Expert Consensus on Clinical Application of Dieda Huoxue Capsules
Expert Consensus on Clinical Application of Dieda Huoxue Capsules

Related Author

CUI Xin
ZHANG Hongchun
YU Xuefeng
XIE Yanming
LI Xin
ZHANG Hongchun
YU Xuefeng
GUO Weiwei

Related Institution

Sino-Japan Friendship Hospital
Chinese People's Liberation Army General Hospital
Qiandongnan Institute of Ethnic Medicine and Affiliated Miao Hospital
Sino-Japanese Friendship Hospital
Qiandongnan Institute of Ethnic Medicine and Affiliated Miao Hospital
0